We are ISO 9001 : 2015 certified, This means that Pharmya has implemented high quality standards. all processes and procedures have been carefully designed and quality-tested according to international standards.
This 5th Update captures the important progress made in the development of the pharmacovigilance information systems and services. These systems will contribute to public health through optimisation of the safe and effective use of medicines. They should also facilitate pharmacovigilance,…
L’application du Règlement UE n° 536/2014 impose de nouvelles modalités de travail pour les autorités compétentes et les Comités d’éthique des Etats membres. Son entrée en vigueur interviendra au plus tôt le 28 mai 2016, sous réserve de la mise…
The EMA releases an updated version of the GVP Module IV, Pharmacovigilance audits. Changes include: Addition of an explanatory note for the definition of audit in footnote 3 on page 5; Editorial improvements in line with the overall GVP style.…
Publié par J Clin Oncol, 26 Janvier 2015 Les auteurs en concluent que la collecte des données de tolérance dans les essais cliniques pourrait également intégrer un recueil en provenance des patients (en plus des données médicales). Voir article
Published by EMA, Feb 2015 The EMA has recently published some presentations explaining how to submit PSURs to the PSUR Repository. Existing gateway users New gateway Users
On 16 September 2014, a new revision of Module VI on Management and Reporting of Adverse Reactions to Medicinal Products came into effect. GVP Module VI has been revised to provide clarification on the clock start for reporting…
On 16 September 2014, a new revision of Module III on Pharmacovigilance Inspections came into effect. GVP Module III has now been revised to include reference to the new EU procedure on the coordination of pharmacovigilance inspections, which came into…